MedPath

Transcutaneous Electrical Acupoint Stimulation on Gastrointestinal Function After Cesarean Section

Not Applicable
Completed
Conditions
Cesarean Section
Registration Number
NCT02416310
Lead Sponsor
Xijing Hospital
Brief Summary

To determine whether treating by transcutaneous electrical acupoint stimulation (TEAS) during perioperative could alleviate the postoperative gastrointestinal complications after cesarean section under combined spinal epidural anesthesia compared with control and non-acupoint group.

Detailed Description

Acupuncture is a traditional Chinese medical technique that involves the insertion of needles at acupoints to treat diseases.Clinical evidence supports the efficacy of acupuncture treatment in many applications. Some previous studies reported that stimulation at some acupoint exerted good effects on the digestive system.Compared with acupuncture, transcutaneous electric acupoint stimulation(TEAS) is a non-invasive technique that has similar effects to acupuncture.We hypothesize that TEAS before anesthesia and during surgery would decrease the morbidity and mortality of postoperative complications in 30 days after Cesarean section.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
150
Inclusion Criteria
  1. ASA physical status 1or2, scheduled for elective cesarean section under combined spinal epidural anesthesia
  2. Gestational age ≥38 weeks
  3. Provide written informed consent
Exclusion Criteria
  1. ASA status≥Ⅲ
  2. Patients undergoing surgery within 12 h of admission to hospital
  3. Patients with fetal anomaly,medical or obstetric complications such as Diabetes mellitus、Hypertension、Obesity(BMW≥35)
  4. Patients suffered from drug addiction or impaired mental state
  5. Patients who have a history of gastrointestinal surgery or chronic gastrointestinal disease.
  6. Patients with contraindications to the use of electro-acupuncture, such as skin damage or infection at the acupoints
  7. Patients with experience of transcutaneous electrical stimulation treatment
  8. Participate in the other clinical trial 3 months before the enrollment
  9. Not suitable to participate in this experiment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Time to the presence of bowel sound, time to the first passage of flatus, time to the first passage of stool , time to the start of regular dietParticipants will be followed for the duration of hospital stay, an expected average of 5 days

This is a composite outcome to estimate the gastrointestinal motility function

Secondary Outcome Measures
NameTimeMethod
Rate of nausea, vomiting, cramping abdominal pain, abdominal distensionParticipants will be followed for the duration of hospital stay, an expected average of 5 days

This is a composite outcome to estimate the complication of digestive system

ElectrogastrogramThe first and second days after surgery
length of postoperative hospital stayParticipants will be followed for the duration of hospital stay, an expected average of 5 days
Quality of life during 30 days after surgeryOne month

This is a scale to evaluate the quality of life after surgery

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.